Patents by Inventor Daniel A. ERKES

Daniel A. ERKES has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • CMV-based intra-tumoral cancer therapies
    Patent number: 11351237
    Abstract: A CMV-based vaccine that promotes immune-mediated destruction of cancer through a onetime or repeated intratumoral administration of a recombinant CMV to generate a robust, long-lasting anti-tumor immune response.
    Type: Grant
    Filed: December 21, 2016
    Date of Patent: June 7, 2022
    Assignee: THOMAS JEFFERSON UNIVERSITY
    Inventors: Christopher M. Snyder, Daniel A. Erkes
  • INTRA-LESIONAL CMV-BASED CANCER VACCINES
    Publication number: 20200164054
    Abstract: A CMV-based vaccine that promotes immune-mediated destruction of cancer through a onetime or repeated intratumoral administration of a recombinant CMV to generate a robust, long-lasting anti-tumor immune response.
    Type: Application
    Filed: December 21, 2016
    Publication date: May 28, 2020
    Applicant: THOMAS JEFFERSON UNIVERSITY
    Inventors: Christopher M. SNYDER, Daniel A. ERKES